Bionano Genomics, Inc. Operating Cash Flow
Bionano Genomics, Inc. (BNGO) reported Operating Cash Flow of -$10.39 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-10
- Bionano Genomics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$4.67M.
- Bionano Genomics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$5.72M.
- Bionano Genomics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$4.17M.
- Bionano Genomics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$5.92M.
- Bionano Genomics, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$16.34M.
- Bionano Genomics, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$68.92M.
- Bionano Genomics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$125.18M.
- Bionano Genomics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$124.82M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$4.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$10.39M 10-Q · filed 2026-08-10 | -$14.56M derived: sum of 3 quarters · filed 2026-08-10 | -$20.48M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | -$5.72M 10-Q · filed 2026-05-13 | -$9.89M derived: sum of 2 quarters · filed 2026-05-13 | -$15.81M derived: sum of 3 quarters · filed 2026-05-13 | -$19.30M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | -$4.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$10.09M derived: sum of 2 quarters · filed 2026-03-23 | -$13.58M derived: sum of 3 quarters · filed 2026-08-10 | -$16.34M 10-K · filed 2026-03-23 | ||||
| 2025-09-30 | -$5.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$9.41M derived: sum of 2 quarters · filed 2026-08-10 | -$12.17M 10-Q · filed 2025-11-13 | -$18.67M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | -$3.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$6.25M 10-Q · filed 2026-08-10 | -$12.76M derived: sum of 3 quarters · filed 2026-08-10 | -$26.06M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | -$2.76M 10-Q · filed 2026-05-13 | -$9.27M derived: sum of 2 quarters · filed 2026-05-13 | -$22.58M derived: sum of 3 quarters · filed 2026-05-13 | -$43.55M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | -$6.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$19.81M derived: sum of 2 quarters · filed 2026-03-23 | -$40.79M derived: sum of 3 quarters · filed 2026-03-23 | -$68.92M 10-K · filed 2026-03-23 | ||||
| 2024-09-30 | -$13.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$34.29M derived: sum of 2 quarters · filed 2025-11-13 | -$62.42M 10-Q · filed 2025-11-13 | -$92.20M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | -$20.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$49.11M 10-Q · filed 2025-08-14 | -$78.89M derived: sum of 3 quarters · filed 2025-08-14 | -$105.18M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | -$28.13M 10-Q · filed 2025-05-14 | -$57.91M derived: sum of 2 quarters · filed 2025-05-14 | -$84.20M derived: sum of 3 quarters · filed 2025-05-14 | -$120.90M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | -$29.78M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$56.07M derived: sum of 2 quarters · filed 2025-03-31 | -$92.77M derived: sum of 3 quarters · filed 2025-03-31 | -$125.18M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | -$26.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$62.99M derived: sum of 2 quarters · filed 2024-11-14 | -$95.40M 10-Q · filed 2024-11-14 | -$129.92M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | -$36.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$69.11M 10-Q · filed 2024-08-07 | -$103.63M derived: sum of 3 quarters · filed 2024-08-07 | -$133.10M derived: sum of 4 quarters · filed 2024-08-07 | ||||
| 2023-03-31 | -$32.41M 10-Q · filed 2024-05-08 | -$66.93M derived: sum of 2 quarters · filed 2024-05-08 | -$96.40M derived: sum of 3 quarters · filed 2024-05-08 | -$124.73M derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | -$34.52M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$63.99M derived: sum of 2 quarters · filed 2024-03-05 | -$92.32M derived: sum of 3 quarters · filed 2024-03-05 | -$124.82M 10-K · filed 2024-03-05 | ||||
| 2022-09-30 | -$29.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$57.80M derived: sum of 2 quarters · filed 2023-11-08 | -$90.30M 10-Q · filed 2023-11-08 | -$115.92M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | -$28.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$60.83M 10-Q · filed 2023-08-09 | -$86.45M derived: sum of 3 quarters · filed 2023-08-09 | -$106.43M derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | -$32.49M 10-Q · filed 2023-05-09 | -$58.12M derived: sum of 2 quarters · filed 2023-05-09 | -$78.10M derived: sum of 3 quarters · filed 2023-05-09 | -$90.52M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | -$25.62M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$45.60M derived: sum of 2 quarters · filed 2023-03-09 | -$58.02M derived: sum of 3 quarters · filed 2023-03-09 | -$71.93M 10-K · filed 2023-03-09 | ||||
| 2021-09-30 | -$19.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$32.40M derived: sum of 2 quarters · filed 2022-11-03 | -$46.30M 10-Q · filed 2022-11-03 | -$58.41M derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | -$12.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$26.32M 10-Q · filed 2022-08-04 | -$38.43M derived: sum of 3 quarters · filed 2022-08-04 | -$49.39M derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | -$13.90M 10-Q · filed 2022-05-05 | -$26.01M derived: sum of 2 quarters · filed 2022-05-05 | -$36.97M derived: sum of 3 quarters · filed 2022-05-05 | -$44.19M derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | -$12.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$23.06M derived: sum of 2 quarters · filed 2022-03-01 | -$30.28M derived: sum of 3 quarters · filed 2022-03-01 | -$38.31M 10-K · filed 2022-03-01 | -$38.31M 10-K · filed 2021-03-23 | |||
| 2020-09-30 | -$10.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$18.18M derived: sum of 2 quarters · filed 2021-11-04 | -$26.21M 10-Q · filed 2021-11-04 | -$35.59M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | -$7.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$15.25M 10-Q · filed 2021-08-04 | -$24.63M derived: sum of 3 quarters · filed 2021-08-04 | -$31.91M derived: sum of 4 quarters · filed 2021-08-04 | ||||
| 2020-03-31 | -$8.03M 10-Q · filed 2021-05-13 | -$17.41M derived: sum of 2 quarters · filed 2021-05-13 | -$24.69M derived: sum of 3 quarters · filed 2021-05-13 | -$31.01M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | -$9.38M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | -$16.66M derived: sum of 2 quarters · filed 2021-03-23 | -$22.98M derived: sum of 3 quarters · filed 2021-03-23 | -$29.53M 10-K · filed 2021-03-23 | ||||
| 2019-09-30 | -$7.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$13.60M derived: sum of 2 quarters · filed 2020-11-13 | -$20.15M 10-Q · filed 2020-11-13 | -$20.05M 10-Q · filed 2019-11-07 | -$24.24M derived: sum of 4 quarters · filed 2020-11-13 | |||
| 2019-06-30 | -$6.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$12.87M 10-Q · filed 2020-08-13 | -$12.87M 10-Q · filed 2019-08-08 | -$16.96M derived: sum of 3 quarters · filed 2020-08-13 | -$23.06M derived: sum of 4 quarters · filed 2020-08-13 | |||
| 2019-03-31 | -$6.55M 10-Q · filed 2020-06-18 | -$6.55M 10-Q · filed 2019-05-09 | -$10.64M derived: sum of 2 quarters · filed 2020-06-18 | -$16.74M derived: sum of 3 quarters · filed 2020-06-18 | -$19.71M derived: sum of 4 quarters · filed 2020-06-18 | |||
| 2018-12-31 | -$4.09M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | -$10.19M derived: sum of 2 quarters · filed 2020-03-10 | -$13.16M derived: sum of 3 quarters · filed 2020-03-10 | -$19.94M 10-K · filed 2020-03-10 | ||||
| 2018-09-30 | -$6.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$9.07M derived: sum of 2 quarters · filed 2019-11-07 | -$15.85M 10-Q · filed 2019-11-07 | -$18.66M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | -$2.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$9.75M 10-Q · filed 2019-08-08 | -$12.56M derived: sum of 3 quarters · filed 2019-08-08 | |||||
| 2018-03-31 | -$6.79M 10-Q · filed 2019-05-09 | -$9.60M derived: sum of 2 quarters · filed 2019-05-09 | ||||||
| 2017-12-31 | -$2.81M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$20.82M 10-K · filed 2019-03-14 | ||||||
| 2017-09-30 | -$18.01M 10-Q · filed 2018-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |